Appendix Table 2.
Pairwise Comparisons by Treatment Group at 18 Monthsa
Established vs. Advice Only Mean (95% CI) | P-Value | Established + DASH vs. Advice Only Mean (95% CI) | P-Value | Established + DASH vs. Established Mean (95% CI) | P-Value | |
---|---|---|---|---|---|---|
LDL Cholesterol (mg/dL) | ||||||
All | −2.0 (−5.3 to 1.4) | .25 | 1.1 (−2.4 to 4.6) | .54 | 3.1 (−0.7 to 6.8) | .11 |
LDL ≥ 130 mg/dL | −5.0 (−10.1 to 0.0) | .05 | −0.7 (−5.6 to 4.2) | .79 | 4.4 (−1.2 to 9.9) | .12 |
LDL < 130 mg/dL | 1.3 (−3.1 to 5.6) | .56 | 3.4 (−1.6 to 8.4) | .18 | 2.1 (−3.0 to 7.2) | .42 |
HDL Cholesterol (mg/dL) | ||||||
All | 1.5 (0.3 to 2.8) | .01 | 0.7 (−0.4 to 1.8) | .19 | −0.8 (−2.1 to 0.4) | .19 |
HDL ≥ 40 mg/dL (Male) and 50 mg/dL (Female) | 1.4 (−0.5 to 3.3) | .16 | −0.2 (−1.9 to 1.5) | .84 | −1.5 (−3.5 to 0.5) | .13 |
HDL < 40 mg/dL (Male) and 50 mg/dL (Female) | 1.7 (0.2 to 3.2) | .02 | 1.8 (0.3 to 3.2) | .01 | 0.03 (−1.4 to 1.5) | .97 |
Triglycerides (mg/dL) | ||||||
All | −7.0 (−15.9 to 1.9) | .12 | −3.2 (−13.5 to 7.0) | .53 | 3.8 (−5.7 to 13.3) | .44 |
Triglyceride ≥ 200 mg/dL | −17.7 (−58.7 to 23.2) | .39 | −16.0 (−61.4 to 29.5) | .49 | 1.8 (−36.0 to 39.6) | .93 |
Triglyceride < 200 mg/dL | −5.7 (−12.3 to 1.0) | .09 | −0.7 (−8.0 to 6.6) | .85 | 5.0 (−2.5 to 12.6) | .19 |
Total Cholesterol (mg/dL) | ||||||
All | −1.5 (−5.3 to 2.2) | .42 | 1.9 (−2.9 to 4.9) | .62 | 2.5 (−1.6 to 6.7) | .23 |
Total Cholesterol ≥ 240 mg/dL | −3.1 (−13.6 to 7.5) | .57 | −0.8 (−12.2 to 10.7) | .90 | 2.3 (−9.1 to 13.7) | .69 |
Total Cholesterol < 240 mg/dL | −1.1 (−5.1 to 2.9) | .58 | 1.5 (−2.6 to 5.5) | .47 | 2.6 (−1.8 to 7.0) | .24 |
Data are presented as mean difference (95% Confidence Interval) unless otherwise indicated